GeoVax Labs, Inc. (GOVX) DCF Valuation

Geovax Labs, Inc. (GOVX) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
GeoVax Labs, Inc. (GOVX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

GeoVax Labs, Inc. (GOVX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Optimice su tiempo y mejore la precisión con nuestra calculadora DCF (GOVX)! Equipado con datos reales de Geovax Labs, Inc. y suposiciones personalizables, esta herramienta le permite pronosticar, analizar y valorar Geovax como un inversor experimentado.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1.2 1.8 .4 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 55.03 -78.88 -78.96 -100 -50.7 -50.7 -50.7 -50.7 -50.7
EBITDA -2.4 -2.8 -18.5 -14.0 -26.7 .0 .0 .0 .0 .0
EBITDA, % -200.51 -153.31 -4813.12 -17249.73 100 -60 -60 -60 -60 -60
Depreciation .0 .0 .0 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 0.7101 1.08 10.01 69.49 100 36.26 36.26 36.26 36.26 36.26
EBIT -2.4 -2.8 -18.6 -14.0 -26.7 .0 .0 .0 .0 .0
EBIT, % -201.22 -154.39 -4823.12 -17319.21 100 -60 -60 -60 -60 -60
Total Cash .3 9.9 11.4 27.6 6.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .2 .0 .0 .0
Account Receivables, % 5.83 10.02 12.73 0 100
Inventories .0 -.2 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 -10.02 -12.73 0 100 15.45 15.45 15.45 15.45 15.45
Accounts Payable .2 .3 2.1 1.7 2.8 .0 .0 .0 .0 .0
Accounts Payable, % 12.98 14.68 534.42 2157.63 100 65.53 65.53 65.53 65.53 65.53
Capital Expenditure .0 -.2 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -0.64683 -8.6 -12.39 -165.75 100 -24.33 -24.33 -24.33 -24.33 -24.33
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.4 -2.8 -18.5 -14.0 -26.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.3 -2.7 -16.7 -14.4 -25.7 -2.8 .0 .0 .0 .0
WACC, % 19.12 19.12 19.12 19.12 19.12 19.12 19.12 19.12 19.12 19.12
PV UFCF
SUM PV UFCF -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -6
Equity Value 4
Diluted Shares Outstanding, MM 3
Equity Value Per Share 1.61

What You Will Get

  • Genuine GeoVax Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for GeoVax Labs, Inc. (GOVX).
  • Comprehensive Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
  • Immediate Valuation Updates: Automatic recalculations to assess the impact of changes on GeoVax's fair value.
  • Flexible Excel Template: Designed for quick edits, scenario testing, and in-depth projections tailored to GeoVax Labs, Inc. (GOVX).
  • Efficient and Precise: Avoid the hassle of building models from scratch while ensuring accuracy and adaptability.

Key Features

  • Comprehensive Data: GeoVax's historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: View GeoVax's intrinsic value recalculated instantly.
  • Intuitive Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Examine GeoVax Labs, Inc.'s pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for investment strategies.

Why Choose This Calculator for GeoVax Labs, Inc. (GOVX)?

  • Accurate Data: Up-to-date GeoVax financials provide dependable valuation outcomes.
  • Customizable: Modify essential parameters like growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate interface and detailed instructions make it accessible for everyone.

Who Should Use This Product?

  • Investors: Accurately assess GeoVax Labs, Inc.’s (GOVX) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to the biotech industry.
  • Consultants: Efficiently modify the template for valuation reports tailored to clients in the healthcare sector.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques in biotechnology.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for GeoVax Labs, Inc. (GOVX).
  • Real-World Data: GeoVax Labs’ historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for deeper insights into GeoVax Labs’ performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to GeoVax Labs, Inc. (GOVX).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to GeoVax Labs, Inc. (GOVX).

No products were found matching.